Literature DB >> 12271430

Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique.

T Brunkhorst1, A R Boerner, S Bergh, D Otto, F W Gratz, W H Knapp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12271430     DOI： 10.1007/s00259-002-0964-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma.

Authors:  C Franzius; S Bielack; J Sciuk; B Vollet; H Jürgens; O Schober
Journal:  Nuklearmedizin       Date:  1999       Impact factor: 1.379

2.  Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma.

Authors:  N Tse; C Hoh; R Hawkins; M Phelps; J Glaspy
Journal:  Am J Clin Oncol       Date:  1994-02       Impact factor: 2.339

3.  Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.

Authors:  M Schulte; D Brecht-Krauss; M Werner; E Hartwig; M R Sarkar; P Keppler; J Kotzerke; A Guhlmann; G Delling; S N Reske
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

4.  FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.

Authors:  C Franzius; J Sciuk; H E Daldrup-Link; H Jürgens; O Schober
Journal:  Eur J Nucl Med       Date:  2000-09
  4 in total
  1 in total

1.  (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.

Authors:  M Beheshti; F M Mottaghy; F Paycha; F F F Behrendt; T Van den Wyngaert; I Fogelman; K Strobel; M Celli; S Fanti; F Giammarile; B Krause; W Langsteger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-23       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.